Secondary Logo

Journal Logo

You can read the full text of this article if you:

Access through Ovid
Editorial Comment

Is it time to retire efavirenz as a first-line option worldwide?

Guanira, Juan V.a; Fichtenbaum, Carl J.b

Author Information
doi: 10.1097/QAD.0000000000003101
  • Buy
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.